Index of reports
> Life Threatening Events (75)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Lithium Carbonate (Lithium) life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 75 Next >>
Possible Lithium Carbonate side effects in 52 year old male
Reported by a physician from Turkey on 2012-08-15
Patient: 52 year old male
Reactions: Death, Toxicity To Various Agents
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Ramipril
Carvedilol
Denan
Persantine
Aspirin
Lithium Carbonate
Possible Lithium Carbonate side effects in 52 year old male
Reported by a health professional (non-physician/pharmacist) from Turkey on 2012-08-15
Patient: 52 year old male
Reactions: Death, Toxicity To Various Agents
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Lithium Carbonate
Persantine
Ramipril
Carvedilol
Denan
Aspirin
Possible Lithium Carbonate side effects in 79 year old female
Reported by a physician from Germany on 2012-08-08
Patient: 79 year old female
Reactions: Pulmonary Hypertension, Vomiting, Nausea, Aphasia, Drug Interaction, Ataxia, Hyponatraemia, Toxicity To Various Agents, Somnolence, Tremor, Panic Attack, Incontinence, Renal Failure, Fatigue, Diarrhoea, Coordination Abnormal
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Lithium Carbonate
Other drugs received by patient possibly interacting with the suspect drug: Amiodarone HCL
Dosage: 3x20mg, 1x/day
Administration route: Oral
Indication: Atrial Fibrillation
Start date: 2012-06-08
End date: 2012-06-15
Spironolactone
Dosage: 10mg 10mg- 5mg-0mg daily
Indication: Pulmonary Arterial Hypertension
Start date: 2012-06-08
End date: 2012-06-16
Ramipril
Dosage: 2.5 mg, unk
Start date: 2012-04-29
End date: 2012-06-16
Other drugs received by patient: Darifenacin; Hydrochlorothiazide; Allopurinol; Xarelto; Torasemide; Bisoprolol; Levothyroxine Sodium
Possible Lithium Carbonate side effects in 79 year old female
Reported by a physician from Germany on 2012-08-03
Patient: 79 year old female
Reactions: Pulmonary Hypertension, Aphasia, Drug Interaction, Somnolence, Incontinence, Fatigue, Coordination Abnormal, Vomiting, Nausea, Hyponatraemia, Ataxia, Toxicity To Various Agents, Tremor, Panic Attack, Renal Failure, Diarrhoea
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Lithium Carbonate
Other drugs received by patient possibly interacting with the suspect drug: Ramipril
Dosage: 2.5 mg, unk
Start date: 2012-04-29
End date: 2012-06-16
Spironolactone
Dosage: 10mg 10mg- 5mg-0mg daily
Indication: Pulmonary Arterial Hypertension
Start date: 2012-06-08
End date: 2012-06-16
Amiodarone HCL
Dosage: 3x20mg, 1x/day
Administration route: Oral
Indication: Atrial Fibrillation
Start date: 2012-06-08
End date: 2012-06-15
Other drugs received by patient: Xarelto; Allopurinol; Torasemide; Bisoprolol; Darifenacin; Hydrochlorothiazide; Levothyroxine Sodium
Possible Lithium Carbonate side effects in 73 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-06-29
Patient: 73 year old male, weighing 70.0 kg (154.0 pounds)
Reactions: Vomiting
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Mirtazapine
Dosage: 3 dose forms,daily
Administration route: Oral
End date: 2006-01-20
Debridat
Dosage: 3 dose forms,daily
Administration route: Oral
Indication: Abdominal Discomfort
Start date: 2006-01-17
End date: 2006-01-20
Tercian
Administration route: Oral
End date: 2006-01-20
Lithium Carbonate
Dosage: 2.5 dose forms,daily
Administration route: Oral
End date: 2006-01-20
Effexor
Dosage: 2 dose forms,daily
Administration route: Oral
End date: 2006-01-20
Possible Lithium Carbonate side effects in 73 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-06-27
Patient: 73 year old male, weighing 70.0 kg (154.0 pounds)
Reactions: Vomiting
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Lithium Carbonate
Dosage: 1000 mg, 1x/day
Administration route: Oral
Indication: Bipolar Disorder
End date: 2006-01-20
Effexor
Dosage: 100 mg, 3x/day
Administration route: Oral
Indication: Bipolar Disorder
End date: 2006-01-20
Debridat
Dosage: 3 df, 1x/day
Administration route: Oral
Indication: Abdominal Discomfort
Start date: 2006-01-17
End date: 2006-01-20
Mirtazapine
Dosage: 45 mg, 1x/day
Administration route: Oral
Indication: Bipolar Disorder
End date: 2006-01-20
Tercian
Dosage: 25 mg, 1x/day
Administration route: Oral
Indication: Bipolar Disorder
End date: 2006-01-20
Possible Lithium Carbonate side effects in 32 year old male
Reported by a physician from Taiwan, Province of China on 2012-06-27
Patient: 32 year old male
Reactions: Respiratory Failure, Catatonia, Neuroleptic Malignant Syndrome, Chronic Hepatitis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Benztropine Mesylate
Indication: Schizoaffective Disorder
Lithium Carbonate
Dosage: 300 mg
Indication: Schizoaffective Disorder
Risperidone
Dosage: 4 mg
Indication: Schizoaffective Disorder
Venlafaxine
Dosage: 150 mg
Indication: Schizoaffective Disorder
Paliperidone
Dosage: 3 mg
Indication: Schizoaffective Disorder
Possible Lithium Carbonate side effects in 55 year old female
Reported by a consumer/non-health professional from United States on 2012-06-08
Patient: 55 year old female, weighing 66.2 kg (145.7 pounds)
Reactions: Renal Failure Chronic
Adverse event resulted in: life threatening event, disablity
Drug(s) suspected as cause:
Eskalith
Dosage: 1 300mg in am and 2 300mg @pm
Indication: Bipolar Disorder
Start date: 1987-01-01
End date: 2008-09-01
Lithium Carbonate
Dosage: 1 300mg in am and 2 300mg @ pm
Indication: Bipolar Disorder
Start date: 1987-01-16
End date: 2008-09-01
Possible Lithium Carbonate side effects in 59 year old male
Reported by a consumer/non-health professional from United States on 2012-06-04
Patient: 59 year old male
Reactions: Rhabdomyolysis, Diplegia, Mental Status Changes, Continuous Haemodiafiltration, Axonal Neuropathy, Toxicity To Various Agents, Renal Failure Acute
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Lithium Carbonate
Possible Lithium Carbonate side effects in 50 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-31
Patient: 50 year old female
Reactions: Rhabdomyolysis, Dystonia, Encephalitis, Pyrexia, Toxicity To Various Agents, Nephrogenic Diabetes Insipidus, Urine Output Increased, Convulsion, Malaise, Urine Osmolarity Increased, Acute Psychosis, Neuroleptic Malignant Syndrome, Renal Failure Acute
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Mefenamic Acid
Dosage: unknown
Indication: Product Used FOR Unknown Indication
Quetiapine
Dosage: 100 mg, unknown. dose and form modified by psychiatry - now 700mg.
Indication: Product Used FOR Unknown Indication
Lithium Carbonate
Dosage: unknown
Indication: Bipolar Disorder
Clomipramine HCL
Dosage: unknown
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Omeprazole; Levothyroxine Sodium; Baclofen
Possible Lithium Carbonate side effects in female
Reported by a individual with unspecified qualification from United States on 2012-05-30
Patient: female, weighing 54.4 kg (119.7 pounds)
Reactions: Renal Disorder
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Lithium Carbonate
Possible Lithium Carbonate side effects in 50 year old female
Reported by a individual with unspecified qualification from United Kingdom on 2012-05-30
Patient: 50 year old female
Reactions: Rhabdomyolysis, Dystonia, Encephalitis, Toxicity To Various Agents, Nephrogenic Diabetes Insipidus, Convulsion, Urine Output Increased, Malaise, Urine Osmolarity Increased, Acute Psychosis, Neuroleptic Malignant Syndrome, Renal Failure Acute
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Quetiapine
Dosage: (100 mg, )
Clomipramine HCL
Lithium Carbonate
Mefenamic Acid
Other drugs received by patient: Levothyroxine (Unknown); Omeprazole; Baclofen
Possible Lithium Carbonate side effects in 50 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-29
Patient: 50 year old female
Reactions: Rhabdomyolysis, Neuroleptic Malignant Syndrome, Toxicity To Various Agents, Nephrogenic Diabetes Insipidus, Renal Failure Acute
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Mefenamic Acid
Indication: Product Used FOR Unknown Indication
Clomipramine HCL
Indication: Product Used FOR Unknown Indication
Lithium Carbonate
Indication: Product Used FOR Unknown Indication
Quetiapine
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Omeprazole; Baclofen; Levothyroxine Sodium
Possible Lithium Carbonate side effects in 50 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-29
Patient: 50 year old female
Reactions: Rhabdomyolysis, Neuroleptic Malignant Syndrome, Toxicity To Various Agents, Nephrogenic Diabetes Insipidus, Renal Failure Acute
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Clomipramine HCL
Indication: Product Used FOR Unknown Indication
Mefenamic Acid
Indication: Product Used FOR Unknown Indication
Lithium Carbonate
Indication: Product Used FOR Unknown Indication
Quetiapine
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Levothyroxine Sodium; Baclofen; Omeprazole
Possible Lithium Carbonate side effects in 50 year old female
Reported by a pharmacist from United Kingdom on 2012-05-27
Patient: 50 year old female
Reactions: Rhabdomyolysis, Dystonia, Encephalitis, Toxicity To Various Agents, Pyrexia, Convulsion, Nephrogenic Diabetes Insipidus, Urine Output Increased, Malaise, Urine Osmolarity Increased, Acute Psychosis, Neuroleptic Malignant Syndrome, Renal Failure Acute
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Clomipramine HCL
Lithium Carbonate
Mefenamic Acid
Quetiapine
Dosage: dose and form modified by psychiatry - now 700mg mr.
Other drugs received by patient: Baclofen; Omeprazole; Levothyroxine Sodium
Possible Lithium Carbonate side effects in 50 year old female
Reported by a pharmacist from United Kingdom on 2012-05-24
Patient: 50 year old female
Reactions: Rhabdomyolysis, Dystonia, Encephalitis, Pyrexia, Toxicity To Various Agents, Nephrogenic Diabetes Insipidus, Convulsion, Urine Output Increased, Malaise, Urine Osmolarity Increased, Acute Psychosis, Neuroleptic Malignant Syndrome, Renal Failure Acute
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Quetiapine Fumarate
Dosage: dose and form modified by psychiatry - now 700mg mg.
Lithium Carbonate
Clomipramine HCL
Mefenamic Acid
Other drugs received by patient: Baclofen; Levothyroxine Sodium; Omeprazole
Possible Lithium Carbonate side effects in 50 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-23
Patient: 50 year old female
Reactions: Rhabdomyolysis, Dystonia, Encephalitis, Pyrexia, Toxicity To Various Agents, Nephrogenic Diabetes Insipidus, Convulsion, Urine Output Increased, Malaise, Urine Osmolarity Increased, Acute Psychosis, Neuroleptic Malignant Syndrome, Apparent Life Threatening Event, Renal Failure Acute
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Quetiapine Fumarate
Dosage: 100 mg
Indication: Product Used FOR Unknown Indication
Lithium Carbonate
Indication: Product Used FOR Unknown Indication
Clomipramine HCL
Indication: Product Used FOR Unknown Indication
Mefenamic Acid
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Levothyroxine Sodium; Omeprazole; Baclofen
Possible Lithium Carbonate side effects in female
Reported by a physician from Indonesia on 2012-05-23
Patient: female
Reactions: Skin Hyperpigmentation, Stevens-Johnson Syndrome
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Lithium Carbonate
Administration route: Oral
Indication: Bipolar Disorder
Lamictal
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Possible Lithium Carbonate side effects in 50 year old female
Reported by a physician from United Kingdom on 2012-05-21
Patient: 50 year old female
Reactions: Rhabdomyolysis, Dystonia, Encephalitis, Toxicity To Various Agents, Pyrexia, Nephrogenic Diabetes Insipidus, Urine Output Increased, Convulsion, Malaise, Urine Osmolarity Increased, Acute Psychosis, Neuroleptic Malignant Syndrome, Renal Failure Acute
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Quetiapine
Administration route: Oral
Lithium Carbonate
Clomipramine HCL
Mefenamic Acid
Other drugs received by patient: Levothyroxine Sodium; Omeprazole; Baclofen
Possible Lithium Carbonate side effects in 50 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-21
Patient: 50 year old female
Reactions: Rhabdomyolysis, Dystonia, Polyuria, Encephalitis, Toxicity To Various Agents, Pyrexia, Nephrogenic Diabetes Insipidus, Urine Output Increased, Convulsion, Malaise, Urine Osmolarity Increased, Acute Psychosis, Blood Sodium Increased, Neuroleptic Malignant Syndrome, Renal Failure Acute
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Clomipramine HCL
Dosage: unk ukn, unk
Quetiapine
Dosage: 100 mg, unk
Mefenamic Acid
Dosage: unk ukn, unk
Lithium Carbonate
Dosage: unk ukn, unk
Other drugs received by patient: Levothyroxine Sodium; Omeprazole; Baclofen
Possible Lithium Carbonate side effects in 54 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-11
Patient: 54 year old male, weighing 128.1 kg (281.8 pounds)
Reactions: Deep Vein Thrombosis
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Desloratadine
Dosage: 5 mg, qd
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Lithium Carbonate
Dosage: 400 mg, qd
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Acetaminophen
Dosage: 1 g, qid
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Amlodipine Besylate
Dosage: 10 mg, qd
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Codeine Sulfate
Dosage: 60 mg, qid
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Quetiapine Fumarate
Dosage: 300 mg, qd
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Senna-Mint WAF
Dosage: 7.5 mg, qd
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Dabigatran Etexilate
Dosage: 220 mg, qd
Administration route: Oral
Indication: Thrombosis Prophylaxis
Start date: 2012-03-27
End date: 2012-04-22
Possible Lithium Carbonate side effects in 54 year old male
Reported by a health professional (non-physician/pharmacist) from Greece on 2012-05-11
Patient: 54 year old male, weighing 128.1 kg (281.8 pounds)
Reactions: Deep Vein Thrombosis
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Quetiapine
Dosage: 300 mg 1 / 1days
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Lithium Carbonate
Dosage: 400mg 1 / 1days
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Acetaminophen
Dosage: 1 g, qid
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Desloratadine
Dosage: 5 mg 1 / 1days
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Dabigatran Etexilate
Dosage: 220 mg 1 / 1days
Administration route: Oral
Indication: Thrombosis Prophylaxis
Start date: 2012-03-27
End date: 2012-04-22
Senna / 00142201 /
Dosage: 7.5 mg 1 / 1days
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Codeine
Dosage: 60 mg, qid
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Amlodipine
Dosage: 10 mg, daily
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Possible Lithium Carbonate side effects in 54 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-11
Patient: 54 year old male, weighing 128.1 kg (281.8 pounds)
Reactions: Deep Vein Thrombosis
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Quetiapine Fumarate
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Senna-Mint WAF
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Dabigatran
Administration route: Oral
Indication: Thrombosis Prophylaxis
Start date: 2012-03-27
End date: 2012-04-22
Codeine Sulfate
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Acetaminophen
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Amlodipine Besylate
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Desloratadine
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Lithium Carbonate
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Possible Lithium Carbonate side effects in 54 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-11
Patient: 54 year old male, weighing 128.1 kg (281.8 pounds)
Reactions: Deep Vein Thrombosis
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Quetiapine Fumarate
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Acetaminophen
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Amlodipine Besylate
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Dabigatran
Administration route: Oral
Indication: Thrombosis Prophylaxis
Start date: 2012-03-27
End date: 2012-04-22
Senna-Mint WAF
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Desloratadine
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Lithium Carbonate
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Codeine Sulfate
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Possible Lithium Carbonate side effects in 54 year old male
Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-05-10
Patient: 54 year old male
Reactions: Deep Vein Thrombosis
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Dabigatran (Dabigatran)
Dosage: 220 mg;qd;po
Administration route: Oral
Indication: Thrombosis Prophylaxis
Start date: 2012-03-27
End date: 2012-04-22
Senna (Senna Alexandria)
Dosage: 7.5 mg;qd;po
Administration route: Oral
Amlodipine
Dosage: 10 mg;qd;po
Administration route: Oral
Desloratadine
Dosage: 5 mg;qd;po
Administration route: Oral
Lithium Carbonate
Dosage: 400 mg;qd;po
Administration route: Oral
Feverall
Dosage: 1 g;qid;po
Administration route: Oral
Codeine Sulfate
Dosage: 60 mg;qid;po
Administration route: Oral
Quetiapine Fumarate
Dosage: 300 mg;qd;po
Administration route: Oral
Possible Lithium Carbonate side effects in 54 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-07
Patient: 54 year old male, weighing 128.1 kg (281.8 pounds)
Reactions: Deep Vein Thrombosis
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Amlodipine
Dosage: 10 mg, 1 in 1 d, oral
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Lithium Carbonate
Dosage: 400 mcg, 1 in 1d, oral
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Senna-Mint WAF
Dosage: 7.5 mg, 1 in 1 d, oral
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Acetaminophen
Dosage: 1 gm, 4 in 1 d, oral
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Quetiapine Fumarate
Dosage: 300 mg, 1 in 1 d, oral
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Dabigatran Etexilate (Dabigatran Etexilate)
Dosage: 220 mg, 1 in 1 d, oral
Administration route: Oral
Indication: Thrombosis Prophylaxis
Start date: 2012-03-27
End date: 2012-04-22
Desloratadine
Dosage: 5 mg, 1 in 1 d, oral
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Codeine Sulfate
Dosage: 60 mg, 4 in 1 d, oral
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Possible Lithium Carbonate side effects in 36 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-04
Patient: 36 year old female
Reactions: Vomiting, Nausea, Hepatotoxicity, Diarrhoea, Serotonin Syndrome, Headache, Neuroleptic Malignant Syndrome
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Sertraline Hydrochloride
Indication: Bipolar Disorder
Loxapine
Indication: Bipolar Disorder
Lamotrigine
Indication: Bipolar Disorder
Ondansetron HCL
Indication: Off Label Use
Ondansetron HCL
Indication: Urinary Tract Infection
Acetaminophen
Indication: Urinary Tract Infection
Ciprofloxacin
Indication: Urinary Tract Infection
Venlafaxine
Indication: Bipolar Disorder
Lithium Carbonate
Indication: Bipolar Disorder
Trazodone Hydrochloride
Indication: Bipolar Disorder
Bupropion Hydrochloride
Indication: Bipolar Disorder
Acetylcysteine
Indication: Toxicity To Various Agents
Possible Lithium Carbonate side effects in 54 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-04
Patient: 54 year old male, weighing 128.1 kg (281.8 pounds)
Reactions: Deep Vein Thrombosis
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Lithium Carbonate
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Codeine
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Dabigatran Etexilate
Administration route: Oral
Indication: Thrombosis Prophylaxis
Start date: 2012-03-27
End date: 2012-04-22
Desloratadine
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Quetiapine
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Acetaminophen
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Senna-Mint WAF
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Acetaminophen
Administration route: Oral
Amlodipine
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Possible Lithium Carbonate side effects in 54 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-03
Patient: 54 year old male, weighing 128.1 kg (281.8 pounds)
Reactions: Deep Vein Thrombosis
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Lithium Carbonate
Dosage: 400 mg
Administration route: Oral
Quetiapine
Dosage: 300 mg
Administration route: Oral
Acetaminophen
Dosage: 1 g
Administration route: Oral
Desloratadine
Dosage: 5 mg
Administration route: Oral
Codeine
Dosage: 60 mg
Administration route: Oral
Senna-Mint WAF
Dosage: 7.5 mg
Administration route: Oral
Pradaxa
Dosage: 220 mg
Administration route: Oral
Indication: Thrombosis Prophylaxis
Start date: 2012-03-27
End date: 2012-04-22
Amlodipine
Dosage: 10 mg
Administration route: Oral
Possible Lithium Carbonate side effects in 54 year old male
Reported by a pharmacist from United Kingdom on 2012-05-03
Patient: 54 year old male, weighing 128.1 kg (281.8 pounds)
Reactions: Deep Vein Thrombosis
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Amlodipine
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Senna-Mint WAF
Dosage: at night
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Lithium Carbonate
Dosage: at night
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Dabigatran Etexilate
Dosage: for 31/7
Administration route: Oral
Indication: Thrombosis Prophylaxis
Start date: 2012-03-27
End date: 2012-04-22
Quetiapine Fumarate
Dosage: at night
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Acetaminophen
Dosage: 500mg-1g qds prn
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Desloratadine
Dosage: every morning
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Codeine
Dosage: 30-60mg qds prn
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Page 1 Next >>
|